ginsenoside rh2 has been researched along with Astrocytoma, Grade IV in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, T; Gao, Y; Guo, W; Li, S; Liu, Y; Ma, W; Zhou, G | 1 |
Gao, Y; Guo, W; Li, S; Liu, Y | 1 |
Guan, N; Guo, W; Huo, X; Luo, J; Zhang, S; Zhang, Z | 1 |
3 other study(ies) available for ginsenoside rh2 and Astrocytoma, Grade IV
Article | Year |
---|---|
EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; ErbB Receptors; Ginsenosides; Glioblastoma; Humans; Male; Mice; Signal Transduction | 2014 |
Ginsenoside Rh2 inhibits growth of glioblastoma multiforme through mTor.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromones; ErbB Receptors; Ginsenosides; Glioblastoma; Humans; Morpholines; Phosphatidylinositol 3-Kinases; Phosphorylation; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13.
Topics: Adult; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Ginsenosides; Glioblastoma; Humans; Male; Matrix Metalloproteinase 13; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Wound Healing | 2015 |